Genomines Bandeau

AI-assisted international press review

Mars Invests $20 Million in Sustainable Rice Amid Climate Challenges

Mars Invests $20 Million in Sustainable Rice Amid Climate Challenges

Mars is investing $20 million by 2030 to transform rice cultivation in the face of climate change. By supporting smart agricultural practices, the initiative aims to reduce greenhouse gas emissions, water usage, and secure farmers' incomes in India, Thailand, and beyond, while safeguarding overall yields. A crucial step for a sustainable future of rice, a staple for billions.

Source: Mars Incorporated, published under the title "Mars investing $20 million in sustainable rice sourcing" - 4 December 2025

Read more
Mars Drives Climate Agriculture in Europe for Healthier Soils

Mars Drives Climate Agriculture in Europe for Healthier Soils

"Crops are reborn and profitability returns, even in tough years": Mars supports 300 European farmers across 60,900 hectares for smart agricultural practices. On World Soil Day, the company urges policymakers to promote public-private partnerships and results-oriented policies to scale these sustainable solutions.

Source: Mars Incorporated, published under the title "Mars champions Europe’s farmers & calls to scale climate-sma..." - 4 December 2025

Read more
Abbott Launches Ensure Shakes to Boost Muscle Health!

Abbott Launches Ensure Shakes to Boost Muscle Health!

Discover how Abbott and Matt Ryan are enhancing muscle health after 40! With the new Ensure Max Protein shakes, combat muscle loss: the 42g option for active adults, rich in protein, vitamins, and electrolytes to build muscle, and the 2-in-1 for seniors, with 30g of protein and CaHMB to slow degradation. Studies also show that protein helps stabilize glucose, promoting lasting vitality. Take charge for a fit life!

Source: Abbott, published under the title "Muscles, The New Flex: Abbott Launches Two New Ensure® Max P..." - 3 December 2025

Read more
Bayer Launches Promising Study on Alport Syndrome!

Bayer Launches Promising Study on Alport Syndrome!

Bayer initiates an innovative clinical trial for BAY 3401016, a monoclonal antibody aimed at blocking Sema3A and slowing kidney damage in Alport syndrome, a rare genetic disease. In collaboration with Evotec and patient associations, this program, which has received FDA Fast Track and Orphan Drug designations, enhances the hope for an effective treatment.

Source: Bayer, published under the title "MediaBayer starts Phase IIa study for treatment of patients ..." - 3 December 2025

Read more
AstraZeneca Accelerates in Hematology with Record at ASH 2025

AstraZeneca Accelerates in Hematology with Record at ASH 2025

AstraZeneca is revolutionizing the management of blood cancers: Promising initial data for surovatamig, a T-cell engager, and AZD0120, a CAR T therapy, in follicular lymphoma and multiple myeloma. Results reinforce the benefits of Calquence in patients with mantle cell lymphoma and chronic lymphocytic leukemia, while Ultomiris confirms its potential in paroxysmal nocturnal hemoglobinuria and in children with post-transplant microangiopathic thrombosis. Advances that redefine the future of hematology.

Source: Astrazeneca, published under the title "AstraZeneca advances haematology and cell therapy ambition w..." - 3 December 2025

Read more
Sanofi Acquires Vicebio to Enhance Its Respiratory Vaccines

Sanofi Acquires Vicebio to Enhance Its Respiratory Vaccines

Sanofi strengthens its leadership in respiratory vaccines: the acquisition of Vicebio brings innovative technology, the 'Molecular Clamp', for a combined vaccine candidate against RSV and HMPV, providing a non-mRNA alternative and expanding options for public health. This strategic move complements Sanofi's pipeline, promoting advancements in the fight against respiratory viruses.

Source: Sanofi, published under the title "Press Release: Sanofi completes acquisition of Vicebio" - 3 December 2025

Read more
Naomi Watts and Johnson & Johnson: Eye Exams, Key to Well-Being After 40

Naomi Watts and Johnson & Johnson: Eye Exams, Key to Well-Being After 40

Alarming revelation: A new survey shows that Americans are neglecting their eye health, despite its major impact on confidence, independence, and early detection of diseases like diabetes or heart disorders. With Naomi Watts and Johnson & Johnson, it's time to prioritize regular check-ups for healthy aging!

Source: J&j, published under the title "Johnson & Johnson Teams Up with Naomi Watts to Reveal Why an..." - 3 December 2025

Read more
SPARK Exceeds Its Training Goals Ahead of Schedule!

SPARK Exceeds Its Training Goals Ahead of Schedule!

CPB Contractors triumphs with the SPARK consortium on the North East Link: 100% of the Major Projects Skills Guarantee (MPSG) target achieved several years ahead of schedule! Over 1.7 million hours dedicated to apprentices, trainees, and cadets, training 689 trainees, 110 apprentices, and 81 cadets, with 52 recognized qualifications and an innovative underground construction program. An exemplary commitment to local jobs and skills enhancement in Victoria.

Source: Cimic, published under the title "Building skills and futures at SPARK" - 3 December 2025

Read more
ACS Expands Partnership with Vulcan for European Lithium Giant

ACS Expands Partnership with Vulcan for European Lithium Giant

ACS Group strengthens its partnership with Vulcan Energy, a pioneer in sustainable lithium in Europe, to orchestrate the green production of 24,000 tons of lithium per year through the Lionheart project. Together with Sedgman and HOCHTIEF, experts in critical minerals, they manage the engineering, construction, and operation of the plants while generating renewable energy. This €169 million investment marks a decisive step towards Europe's energy independence, powering 500,000 electric vehicles without fossil emissions. An innovative collaboration for a sustainable future!

Source: Grupoacs, published under the title "ACS Group expands strategic partnership with Vulcan Energy t..." - 3 December 2025

Read more
ACS and Vulcan Accelerate Sustainable Lithium in Europe

ACS and Vulcan Accelerate Sustainable Lithium in Europe

ACS Group strengthens its partnership with Vulcan Energy, a pioneer in sustainable lithium and renewable energies, by taking a key role in the development of production infrastructure. With Sedgman and HOCHTIEF, the Lionheart project – valued at 734 million euros – will see the construction of plants to extract and process lithium from geothermal sources, producing enough for 500,000 electric vehicles annually, without fossil emissions. This 169 million euro investment from HOCHTIEF underscores the commitment to European independence in critical materials and the energy transition. A major step towards a sustainable and innovative future in Europe!

Source: Cimic - 3 December 2025

Read more
HOCHTIEF and Vulcan: The European Lithium Giant on the Move

HOCHTIEF and Vulcan: The European Lithium Giant on the Move

HOCHTIEF and Sedgman accelerate Vulcan Energy's Lionheart project: sustainable lithium production for 500,000 electric vehicles per year, enabled by zero-carbon geothermal extraction. A €169 million investment, strategic project status under the EU's Critical Raw Materials Act, and a partnership for European energy independence. A significant step towards a clean and innovative future.

Source: Hochtief, published under the title "HOCHTIEF Group expands strategic partnership with Vulcan Ene..." - 3 December 2025

Read more
Bayer Innovates in Pediatric MRI with Low-Dose Agent

Bayer Innovates in Pediatric MRI with Low-Dose Agent

Bayer reveals initial results from the QUANTI Pediatric study for its MRI contrast agent gadoquatrane, an innovative low-dose product that reduces gadolinium exposure by 60% in children from birth to 18 years. This research confirms promising safety and efficacy, supporting market authorization requests with global health authorities for safer medical imaging tailored for younger patients. These advancements could transform practices in pediatric radiology.

Source: Bayer, published under the title "Data from Pediatric Study for Bayer's Investigational MRI Co..." - 2 December 2025

Read more
Nipocalimab: First FcRn Antibody Approved for Generalized Myasthenia Gravis

Nipocalimab: First FcRn Antibody Approved for Generalized Myasthenia Gravis

The European Medicines Agency has approved nipocalimab, an innovative monoclonal antibody, for the treatment of generalized myasthenia gravis in adults and adolescents. This therapeutic advancement aims to reduce IgG levels, which are responsible for the debilitating symptoms of the disease, while preserving immune functions. Clinical study results show significant symptom improvement, providing a new option for patients, estimated to number between 56,000 and 123,000 in Europe.

Source: J&j - 2 December 2025

Read more
Unfair Trading Practices: What the Directive Has Changed
AgrifoodEurope

Unfair Trading Practices: What the Directive Has Changed

According to a commission report, the 2019 Unfair Trading Practices Directive has already contributed to fostering a fairer and more balanced trading environment within the agri-food supply chain. A review is planned to better combat sales below production costs.

Source: European Commission Common Agricultural Policy, published under the title "Commission carried out evaluation of the Directive on unfair..." - 2 December 2025

Read more
Biotalys: EPA Approves Innovative Biofungicide EVOCA
Soils, Inputs & Water

Biotalys: EPA Approves Innovative Biofungicide EVOCA

The Belgian AgTech company Biotalys, specializing in the development of protein-based biocontrol solutions for crop protection, has received approval from the U.S. Environmental Protection Agency for its biofungicide EVOCAâ„¢. The first of its kind in the United States, this product targets botrytis and powdery mildew on fruits and vegetables while preserving the environment and beneficial organisms. A major advancement with registration prospects in California, Florida, and Europe.

Source: Agropages, published under the title "Biotalys receives regulatory approval by U.S. EPA for biofun..." - 2 December 2025

Read more
PepsiCo Accelerates with Mercedes F1: Gatorade, Sting, and Doritos on Track!

PepsiCo Accelerates with Mercedes F1: Gatorade, Sting, and Doritos on Track!

PepsiCo speeds onto the track with the Mercedes-AMG PETRONAS F1 Team! Starting in 2026, Gatorade enhances driver hydration with its scientific expertise, Sting electrifies fans with explosive energy, and Doritos adds a bold touch to racing experiences. This innovative alliance, merging performance and passion, propels the three brands to the heart of motorsport, reinforcing PepsiCo's commitment to excellence and global innovation. A winning fusion to boost athletes and captivate spectators!

Source: Pepsico, published under the title "PepsiCo® announces landmark global partnership with Mercedes..." - 2 December 2025

Read more
Genomics Revolutionizes Agaricomycetes
HealthBiotech & Genetics

Genomics Revolutionizes Agaricomycetes

Agaricomycetes, these ancient fungi, are transforming green technologies and medicine through advancements in genomics.

Source: Springer, published under the title "The biodiversity, genomics, ecology and evolution of mushroo..." - 2 December 2025

Read more
The Melbourne Build Expo: Innovations and Networking in Construction

The Melbourne Build Expo: Innovations and Networking in Construction

Exploring the Melbourne Build Expo: Rochelle Richardson, senior partner at UGL, shares her insights on construction innovations, priorities such as learning, and mental health challenges. Inspiring panels and diverse booths strengthened her network, highlighting the importance of such events to promote her brand and connect industry professionals. An unmissable opportunity to explore trends and support teams on the ground.

Source: Cimic - 2 December 2025

Read more
Historic Agreement for the Resilient Battery Park City Project

Historic Agreement for the Resilient Battery Park City Project

Turner-SPC launches New York's first progressive design-build project to enhance the coastal resilience of Battery Park City. This ambitious partnership, backed by a union work agreement, protects against flooding, creates thousands of sustainable jobs, and promotes the inclusion of minority and women-owned businesses, while advocating for fair wages and opportunities for youth, women, and veterans. An urban innovation for a sustainable climate future.

Source: Hochtief, published under the title "BPCA Announces Project Labor Agreement For $1.7 Billion Batt..." - 2 December 2025

Read more
Future Infrastructure Leaders: Iris and Dylan Join the 2025 Roads Australia Fellowship

Future Infrastructure Leaders: Iris and Dylan Join the 2025 Roads Australia Fellowship

The selection of Iris Garcia and Dylan Kunst for the Roads Australia 2025 fellowship program highlights exceptional talent and leadership at CPB Contractors. This program cultivates future leaders in transport infrastructure, emphasizing curiosity, initiative, and innovation. Iris, a senior engineer on the M6 projects in NSW, excels in complex environments for effective solutions, while Dylan, a construction manager on the West Gate Tunnel in Victoria, leads diverse teams with a focus on safety and collaboration. CPB Contractors thus strengthens diversity and collaboration in the industry.

Source: Cimic, published under the title "Developing our future leaders: Iris and Dylan join the 2025 ..." - 2 December 2025

Read more